TrialHuman vaccines & immunotherapeutics2024

Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study.

Chien-Yu Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.